Upgrades:
Franklin Resources (NYSE:BEN) was upgraded by analysts at
Keefe, Bruyette & Woods from a “market perform” rating to an “outperform”
rating in a report issued on Monday, Briefing.com reports. The firm presently
has a $28.00 target price on the closed-end fund’s stock, up from their
previous target price of $24.00. Keefe, Bruyette & Woods’ price target
points to a potential upside of 19.20% from the company’s current price.
Other equities research analysts also recently issued
research reports about the stock. Credit Suisse Group reaffirmed a “sell”
rating and set a $20.00 price target on shares of Franklin Resources in a
research note on Friday, September 11th. Zacks Investment Research downgraded
shares of Franklin Resources from a “strong-buy” rating to a “hold” rating and
set a $22.00 price target on the stock. in a research note on Wednesday, August
5th. Citigroup upped their price target on shares of Franklin Resources from
$20.00 to $22.75 and gave the company a “neutral” rating in a research note on Thursday,
July 30th. Morgan Stanley started coverage on shares of Franklin Resources in a
research note on Thursday, September 3rd. They set an “underweight” rating and
a $20.00 price target on the stock. Finally, Barclays reissued a “sell” rating
and issued a $19.00 target price on shares of Franklin Resources in a research
note on Friday, July 17th. Six analysts have rated the stock with a sell
rating, nine have given a hold rating and three have issued a buy rating to the
company’s stock. The stock has a consensus rating of “Hold” and an average
target price of $22.67. Read
more …

Kansas City Southern (NYSE:KSU) was upgraded by BMO Capital
Markets from a “market perform” rating to an “outperform” rating in a report
issued on Monday, Anlyst Ratings reports. The firm presently has a $205.00
price target on the transportation company’s stock, up from their previous
price target of $200.00. BMO Capital Markets’ price objective would suggest a
potential upside of 14.52% from the company’s current price.
KSU has been the topic of a number of other reports. Stifel
Nicolaus cut Kansas City Southern from a “buy” rating to a “hold” rating and
set a $162.00 price target on the stock. in a research report on Wednesday,
August 5th. Bank of America increased their target price on Kansas City
Southern from $203.00 to $205.00 and gave the stock a “buy” rating in a
research note on Thursday, September 10th. Morgan Stanley upped their price
target on shares of Kansas City Southern from $136.00 to $138.00 and gave the
stock an “equal weight” rating in a research note on Monday, October 5th.
Credit Suisse Group restated a “buy” rating on shares of Kansas City Southern
in a research note on Friday, August 7th. Finally, Barclays upped their target
price on shares of Kansas City Southern from $150.00 to $175.00 in a research
note on Monday, September 14th. One equities research analyst has rated the
stock with a sell rating, eleven have assigned a hold rating, nine have
assigned a buy rating and one has assigned a strong buy rating to the company’s
stock. Kansas City Southern presently has an average rating of “Hold” and an
average target price of $171.40. Read
more …

Archer Daniels Midland (NYSE:ADM) was upgraded by analysts
at JPMorgan Chase & Co. from a "neutral" rating to an
"overweight" rating in a research report issued on Monday, Anlyst
Ratings reports. The firm presently has a $60.00 price target on the stock.
JPMorgan Chase & Co.'s price objective points to a potential upside of
20.51% from the company's previous close.
A number of other equities research analysts have also
recently commented on ADM. Stifel Nicolaus reduced their target price on shares
of Archer Daniels Midland from $48.00 to $47.00 and set a "buy"
rating for the company in a research report on Tuesday, June 30th. Credit
Suisse Group cut shares of Archer Daniels Midland from a "neutral"
rating to an "underperform" rating and reduced their target price for
the company from $40.00 to $39.00 in a research report on Monday, July 27th.
Stephens started coverage on shares of Archer Daniels Midland in a research
report on Thursday, July 9th. They issued a "buy" rating and a $52.00
target price for the company. Morgan Stanley increased their target price on
shares of Archer Daniels Midland from $40.00 to $45.00 and gave the company an
"equal weight" rating in a research report on Monday, August 10th.
Finally, Seaport Global Securities started coverage on shares of Archer Daniels
Midland in a research report on Tuesday, July 28th. They issued a
"buy" rating and a $51.00 target price for the company. Two equities
research analysts have rated the stock with a sell rating, three have assigned
a hold rating and six have assigned a buy rating to the company's stock. The
company presently has an average rating of "Hold" and an average
target price of $46.20. Read
more …

Bristol-Myers Squibb (NYSE:BMY) was upgraded by analysts at
Guggenheim from a “neutral” rating to a “buy” rating in a research report
issued on Monday, Briefing.com reports. The firm currently has a $70.00 price
target on the biopharmaceutical company’s stock. Guggenheim’s target price
would indicate a potential upside of 14.30% from the company’s previous close.
A number of other research firms have also issued reports on
BMY. Cfra restated a “buy” rating and set a $70.00 price objective on shares of
Bristol-Myers Squibb in a research report on Sunday, July 26th. Berenberg Bank
started coverage on Bristol-Myers Squibb in a research note on Tuesday,
September 29th. They set a “buy” rating and a $73.00 target price on the stock.
Seaport Global Securities started coverage on Bristol-Myers Squibb in a
research note on Tuesday, July 28th. They set an “outperform” rating and a
$75.00 target price on the stock. Raymond James reaffirmed a “buy” rating on
shares of Bristol-Myers Squibb in a research note on Friday, September 25th.
Finally, Morgan Stanley lifted their target price on Bristol-Myers Squibb from
$64.00 to $66.00 and gave the company an “overweight” rating in a research note
on Wednesday, August 12th. One investment analyst has rated the stock with a
sell rating, four have given a hold rating and fourteen have given a buy rating
to the company. The company presently has a consensus rating of “Buy” and a
consensus target price of $70.94. Read
more …